Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma

Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, David F. McDermott, Robert J. Motzer, Abdallah Flaifel, Jean Christophe Pignon, Miriam Ficial, Osvaldo Aren Frontera, Saby George, Thomas Powles, Frede Donskov, Michael R. Harrison, Philippe Barthel Emy, Scott S. Tykodi, Judit Kocsis, Alain Ravaud, Jeronimo R. Rodriguez-Cid, Sumanta K. Pal, Andre M. MuradYuko Ishii, Shruti Shally Saggi, M. Brent McHenry, Brian I. Rini

Research output: Contribution to journal › Article › peer-review

144 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences